Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Mubassir Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology Ministry of Education College of Bioengineering Chongqing University Chongqing, Chongqing, 40…. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 229 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, China Postdoc Science Foundation.
Abstract (Originalsprache)
Melanoma is one of the most severe skin cancer indications with rapid progression and a high risk of metastasis. However, despite the accumulated advances in melanoma treatment including adjuvant radiation, chemotherapy, and immunotherapy, the overall melanoma treatment efficacy in the clinics is still not satisfactory. Interestingly, bacterial therapeutics have demonstrated unique properties for tumor‐related therapeutic applications, such as tumor‐targeted motility, tailorable cytotoxicity, and immunomodulatory capacity of the tumor microenvironment, which have emerged as a promising platform for melanoma therapy. Indeed, the recent advances in genetic engineering and nanotechnologies have boosted the application potential of bacterium‐based therapeutics for treating melanoma by further enhancing their tumor‐homing, cell‐killing, drug delivery, and immunostimulatory capacities. This review provides a comprehensive summary of the state‐of‐the‐art bacterium‐based anti‐melanoma modalities, which are categorized according to their unique functional merits, including tumor‐specific cytotoxins, tumor‐targeted drug delivery platforms, and immune‐stimulatory agents. Furthermore, a perspective is provided discussing the potential challenges and breakthroughs in this area. The insights in this review may facilitate the development of more advanced bacterium‐based therapeutic modalities for improved melanoma treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Biorheological Science and Technology Ministry of Education College of Bioengineering Chongqing University Chongqing, Chongqing, 400044, P. R. China.
- Ruian People's Hospital, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325016, P. R. China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Lab for Vascular Implants College of Bioengineering Chongqing University, Chongqing, 400030, P. R. Chi…
- School of Life Science, Chongqing University, Chongqing, 400044, P. R. China.
ORCID-Profile: Zhong Luo
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- China Postdoc Science Foundation
- Chongqing Municipal Science and Technology Bureau
Zitieren
APA
Khan, M., Dong, Y., Ullah, R., Li, M., Huang, Q., Hu, Y., Yang, L., & Luo, Z. (2024). Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401076
Vancouver
Khan M, Dong Y, Ullah R, Li M, Huang Q, Hu Y, et al. Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401076
BibTeX
@article{Khan2024,
author = {Khan, Mubassir and Dong, Yilong and Ullah, Razi and Li, Menghuan and Huang, Qiping and Hu, Yan and Yang, Li and Luo, Zhong},
title = {Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401076}
}
EUVIMED